Cyclic AMP can promote APL progression and protect myeloid leukemia cells against anthracycline-induced apoptosis

We show that cyclic AMP (cAMP) elevating agents protect blasts from patients with acute promyelocytic leukemia (APL) against death induced by first-line anti-leukemic anthracyclines like daunorubicin (DNR). The cAMP effect was reproduced in NB4 APL cells, and shown to depend on activation of the gen...

Descripción completa

Detalles Bibliográficos
Autores principales: Gausdal, G, Wergeland, A, Skavland, J, Nguyen, E, Pendino, F, Rouhee, N, McCormack, E, Herfindal, L, Kleppe, R, Havemann, U, Schwede, F, Bruserud, Ø, Gjertsen, B T, Lanotte, M, Ségal-Bendirdjian, E, Døskeland, S O
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3734820/
https://www.ncbi.nlm.nih.gov/pubmed/23449452
http://dx.doi.org/10.1038/cddis.2013.39

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3734820/
https://www.ncbi.nlm.nih.gov/pubmed/23449452
http://dx.doi.org/10.1038/cddis.2013.39

Ejemplares similares